No. 4 (tie) – Amgen – 3.7%
Based in Thousand Oaks, Calif., AMGN has developed drugs to treat cancer, arthritis, anemia, osteoporosis and other serious ailments. The company’s robust product line and active pipeline of new treatments ensures its healthy annual cash flows and supports the dividend.